02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
The Equator Principles Association (EPA) has released the much-awaited draft text of Equator Princip...
Read More >
On May 20, 2020, the Securities and Exchange Commission formally adopted amendments to financial dis...
Read More >
Requirement for written employment contracts - Under section 5(a) of the Employment and Skills Dev...
Read More >
Yesterday, the Federal Trade Commission (FTC) announced the annual changes to the thresholds for Sec...
Read More >
This fall, the U.S. Supreme Court heard three employment cases that collectively ask: Does Title VII...
Read More >
The UK Competition and Markets Authority (CMA) has published a document setting out its digital mark...
Read More >